Exploring Artificial Intelligence to help support our Breast Screening Services
28/12/2018 / Artificial Intelligence
28/03/2019 / Artificial Intelligence
emrad is confirmed as one of the 7 winning national sites to be part of the Innovate UK Wave 2 Testbed. Our 18 month project will develop and test the use of Artificial Intelligence within breast screening services.
We have partnered with two small/medium UK start-ups, Faculty AI and Kheiron Medical. Faculty AI are developing a tool to help maximise the resource scheduling and capacity of breast screening services. Kheiron Medical have a CE marked Mammography Intelligent Assessment (MIA) tool which has the potential to act as the second reader and make recall suggestions.
We will use the testbed as an opportunity to develop and test these technologies with a view to being ready to deploy at the end of the project. Regular updates will be posted on this website so watch this space.
The East Midlands Radiology Consortium (emrad) is an alliance of seven NHS Trusts who have joined together and share diagnostic imaging, (X-Rays, CTs, MRIs etc) for the purposes of enhancing patient care and supporting operational capacity.
The consortium is leading a nationally funded 18-month project to develop and test Artificial Intelligence (AI) software within Breast Screening Services in our region. Our NHS consortium has partnered with two small UK start-up companies: Faculty AI and Kheiron Medical to jointly develop AI tools that aim to maximise operational and capacity aspects of the Breast service as well as assisting with clinical and workforce pressures.
Our vision is simply: Through delivering this project we hope to optimise NHS Breast Screening Capacity. We believe by doing this we will help enhance the Care that every woman attending Breast Screening receives. Finally we want to increase NHS and public Confidence in the use of AI and the potential benefits it can bring.